TruthArchive.ai - Related Video Feed

Out of every hundred cases of myocarditis, only one is likely to result in death due to vaccine side effects. However, it is important to note that myocarditis has a high mortality rate of 50% within five years and a significant number of deaths within ten years. This poses significant risks for individuals who develop myocarditis after vaccination. The question remains whether the vaccine is necessary for an epidemic that some argue is no more severe than the flu.

Myocarditis, or heart damage, is more common than previously thought. Studies in the US military and Thailand show that around 20% of people who receive the COVID vaccine develop myocarditis, as confirmed by echocardiograms and other tests. This means that out of every 1 million vaccinated individuals, 200,000 will experience heart damage. Unfortunately, 50% of those with myocarditis will die within 5 years. This alarming increase in myocarditis cases is due to the cardiotoxic nature of the vaccine. This information comes from Dr. Cressel and Shoemaker in Toronto, Canada.

Speaker 1 discusses the progression of understanding around heart damage associated with this product, emphasizing key studies and their implications. He recalls that in 2022 German scientists tested and reported that heart damage seen in myocarditis patients corresponds to vaccine-triggered autoimmune reactions. They examined endomyocardial biopsies and observed that the cardiac detection of the spike protein and CD4+ T cell–dominated inflammation suggested a vaccine-triggered autoimmune process. He notes headlines that infections could cause more myocarditis than vaccination and cites a large Israeli population study from that year finding no increase in myocarditis or pericarditis among unvaccinated individuals, challenging the notion that vaccination is the sole driver. Speaker 1 then highlights a new study published in the American Heart Association journal Circulation, framing it as a major development not from fringe sources but from a prestigious, mainstream journal. He asserts that this study goes beyond epidemiology by demonstrating a mechanism. In an experimental model, mice were used to induce myocarditis-like cardiac damage; researchers then compared these findings to humans who had similar heart damage post-vaccination. They found that T cells from patients with acute myopericarditis recognize vaccine-encoded spike epitopes that are homologous to cardiac self proteins, indicating cross-reactivity where the immune system targets both the spike protein and cardiac proteins. Speaker 1 explains that the study measured functional responses to potassium channels (KV) and observed an expanded pattern of cytokine production in patients with mild pericarditis after mRNA vaccination, but not in patients with COVID-19 without vaccination. This expanded cytokine response mirrored what was seen in AMP (myopericarditis) mice and in autoimmune myocarditis, linking the clinical data with the animal model. He paraphrases the study’s plain-language takeaway: post-mRNA vaccine myopericarditis is driven by molecular mimicry, with the immune system failing to distinguish self from non-self in susceptible patients. The study further notes that vaccine distribution contributes to susceptibility; the widespread distribution of the vaccine allows the heart to be targeted, leading to cardiac-selective autoimmunity by “heart-homing imprinting.” Speaker 1 emphasizes the significance of the source, stating that the journal is not fringe: it is the Circulation journal, ranked third in its field with a cardiovascular-focused impact in the 99th percentile. The overall conclusion presented is that these findings provide a clear mechanism for post-vaccination myopericarditis and establish a direct link between vaccine-encoded spike epitopes and cardiac autoimmunity.

We have administered this type of vaccine to over one billion people, demonstrating its safety. While there is a very low risk of myocarditis, particularly in young men, the risk of developing myocarditis from COVID-19 is actually higher than from the vaccine.

Myocarditis was found more in young men, with rates highest in those aged 16-17. The condition was less common in women and older age groups. Most cases were mild, but some were severe, impacting a person's life. Myocarditis was most common after the second vaccine dose and less frequent in younger children and with subsequent doses. Natural immunity from previous COVID infection was shown to be effective, even more so than two vaccine doses. Combining previous infection with vaccination provided even better protection. The speaker did not take a booster shot. Translation: Myocarditis was more common in young men, especially those aged 16-17. Most cases were mild, but some were severe. The condition was most frequent after the second vaccine dose. Natural immunity from prior COVID infection was found to be effective, even more so than two vaccine doses. Combining previous infection with vaccination provided even better protection. The speaker did not take a booster shot.

The discussion centers on new evidence regarding myocarditis and pericarditis in the context of mRNA vaccination. It cites earlier 2022 German research showing that heart damage seen in myocarditis cases after vaccination may be a vaccine-triggered autoimmune reaction. The study analyzed endomyocardial biopsy samples and found that the cardiac tissue’s spike protein detection and CD4+ T cell–dominated inflammation suggested an autoimmune mechanism linking the vaccine to heart damage. This was contrasted with an Israel-based population study of hundreds of thousands of unvaccinated individuals that reported no increase in myocarditis or pericarditis incidence, highlighting a discrepancy with the vaccine-triggered autoimmune hypothesis. The center of the new claim is a study published in Circulation by the American Heart Association. The speakers emphasize the credibility of Circulation as a top cardiovascular journal. The study used an experimental mouse model to induce cardiac damage and then examined humans with similar heart damage after vaccination to see if the same mechanism applied. They report that T cells from patients with acute myopericarditis recognize vaccine-encoded spike epitopes that are homologous to cardiac self-proteins. In other words, the immune cells targeting the spike protein may also attack cardiac proteins due to molecular similarity. Further details from the study indicate that, in patients with mild pericarditis after mRNA vaccination (but not in those with COVID-19), there was an expanded pattern of cytokine production similar to that observed in myopericarditis–affected mice and in autoimmune myocarditis. The takeaway provided in plain language is that post-mRNA vaccine myopericarditis is driven by molecular mimicry, causing the immune system to fail to distinguish self from non-self in susceptible patients. The susceptibility is described as being influenced by the widespread distribution of the vaccine, which purportedly leads to heart-homing imprinting and a heart-targeted autoimmune response. The speakers stress that this journal is not fringe and highlight its high impact in cardiovascular medicine. They conclude that the data collectively suggest a mechanism by which the vaccine could provoke cardiac autoimmunity, with implications for clinical communication and understanding of post-vaccination myocarditis.

Myocarditis is a rare side effect of the vaccine, with only 1% of cases resulting in death. However, it is important to note that myocarditis has a high mortality rate of 50% within five years and many deaths within ten years. This poses significant risks for individuals who develop myocarditis after vaccination. The question remains whether the vaccine is necessary for an epidemic that some argue is no more severe than the flu.

We are witnessing a significant increase in cases of myocarditis, with thousands reported in recent studies compared to only a few cases in the past. The potential long-term effects of vaccine-induced myocarditis are concerning, with some cases leading to cardiac arrests years after vaccination. This suggests that the current cases may just be the beginning, and regulatory concerns should extend for at least 5 to 15 years post-vaccination.

The discussion centers on evidence linking myocarditis and pericarditis to mRNA vaccination and the proposed mechanism behind it. It references a 2022 German study reporting that endomyocardial biopsy data from people with myocarditis showed cardiac detection of the spike protein and CD4+ T cell–dominated inflammation, suggesting a vaccine-triggered autoimmune reaction. The presenters note headlines at the time comparing myocarditis risk to infection, with claims that infection causes more myocarditis, and remind that vaccines were said not to stop transmission. They then cite a large Israeli population study from the same year involving subjects not vaccinated against SARS-CoV-2, which found no increase in the incidence of myocarditis or pericarditis, implying no observed vaccine-related signal in that cohort. Attention shifts to a more recent study published in Circulation by the American Heart Association, described as a high-impact, non-fringe journal, indicating a clearer mechanism has been demonstrated. The study described used an experimental mouse model to induce cardiac damage and then compared it to human cases with heart damage following vaccination. It states that T cells from patients with acute myocarditis or myopericarditis recognize vaccine-encoded spike epitopes that are homologous to cardiac self proteins, meaning the immune response to the spike protein can cross-react with heart tissues. The researchers further report that functional responses to potassium channels in patients with mild pericarditis after mRNA vaccination, but not in patients with COVID-19, showed an expanded pattern of cytokine production similar to that observed in myopericarditis mice and in autoimmune myocarditis. In plain terms, the summary of their takeaway is that post-mRNA vaccine myopericarditis is driven by molecular mimicry: the immune system cannot distinguish self from non-self, leading to an autoimmune attack on heart tissue in susceptible patients. The distribution of the vaccine (its widespread dissemination) is cited as a factor that makes patients susceptible by promoting heart-homing imprinting, effectively creating an anti-heart autoimmune response. The speakers emphasize that this Circulation article is a top-tier source, underscoring that the mechanism has been demonstrated with both animal models and human pathology, supporting the claim that the phenomenon has a defined immunological basis.

A cardiologist states they have seen thousands of patients with myocarditis since the COVID-19 vaccines became available, compared to only two cases before the pandemic. They cite a New England Journal of Medicine article from Washington University in St. Louis about a 42-year-old man who died three days after taking Moderna. Another case from Korea involved a younger man who died within eight hours of being hospitalized after taking Pfizer; the cardiologist examined the images and said the heart appeared "fried" with inflammation. They argue these cases should have prompted immediate attention and that no one should die from a vaccine. They also mention a publication from Connecticut about two teenage boys, ages 16 and 17, who died a few days after taking Pfizer and were found dead at home.

There is a causal link between vaccination and both myocarditis and pericarditis. The reason for this is still unclear. It may be that the SARS CoV-2 spike protein mimics a protein found on heart muscle cells. If that's the case, when you create an immune response to the SARS CoV-2 spike protein, you could also inadvertently create an immune response to your own heart muscle.

Doctor McCullough, a cardiologist, explains that while heart issues in kids can be rare due to viruses like parvovirus, current estimates show a significant increase to 25,000 cases per million linked to COVID-19 vaccines. He emphasizes that myocarditis is now primarily attributed to the vaccines until proven otherwise.

Before COVID-19, I only encountered two cases of myocarditis in my entire career as a cardiologist. It was a rare condition, usually caused by parvovirus or adenovirus. However, now I see two cases per day in the clinic. We have learned that COVID-19 can cause myocarditis. Various organizations, such as the Israeli and US military, as well as college leagues, conducted screening programs in 2020 and found a few cases, but none were serious or resulted in hospitalizations or deaths. These programs were later discontinued when vaccines were introduced. However, within six months, regulatory agencies confirmed that the COVID-19 vaccines can cause myocarditis, and it can be fatal. It's important for people to understand the risks associated with each vaccine dose they take.

We have experience with this vaccine in a billion people, showing it is safe. The mRNA vaccine carries a very low risk of myocarditis, especially in young men. However, the risk of myocarditis from COVID is higher than from the vaccine.

Out of every hundred cases of myocarditis, only one is likely to result in death due to vaccine side effects. Although the number of myocarditis cases is relatively low, it is crucial to note that myocarditis has a fifty percent mortality rate at five years and a significant number of deaths at ten years. This poses significant risks for individuals who develop myocarditis after vaccination. The ongoing question remains whether the vaccine is necessary for an epidemic that some argue is no more severe than the flu.

In the question, myocarditis is discussed in relation to COVID-19. It has been mentioned for some time that infection with the novel coronavirus can lead to myocarditis, and that in some cases myocarditis can be severe or progress to myocarditis with structural complications. It is noted that myocarditis can also occur after vaccination, but the incidence is small and the symptoms are mild, with most people recovering. The speaker emphasizes that even when myocarditis occurs after vaccination, the risk is small and the condition tends to be mild. The statement asserts that almost all individuals recover from vaccine-associated myocarditis. Therefore, even if people who have received a vaccine develop myocarditis, the situation is not something to be alarmed about. The speaker argues that the benefits of vaccination far outweigh the risks, and that the idea of significant changes or issues related to the vaccine is not supported. The overall conclusion presented is that the risks of myocarditis, whether from infection or vaccination, are outweighed by the benefits of vaccination. Key points reiterated include: - COVID-19 infection can cause myocarditis, sometimes with considerable severity or with structural heart complications. - Myocarditis can also occur after vaccination, but the occurrence is rare and the symptoms are generally mild. - The vast majority of people with vaccine-associated myocarditis recover. - The perceived risk of myocarditis following vaccination should not be a cause for alarm, given that the benefits of vaccination are greater. - There is no indication that anything about the vaccine itself changes in a way that would alter this risk-benefit balance. Overall, the message is that myocarditis is a potential outcome associated with both infection and vaccination, but the frequency is low, the illness is typically mild, recovery is common, and vaccination remains advantageous.

Before COVID-19, I only encountered two cases of myocarditis in my entire career as a cardiologist. It was a rare condition, usually caused by parvovirus or adenovirus. However, now I see two cases per day in the clinic. We have learned that COVID-19 can cause myocarditis. Various organizations, such as the Israeli and US military, as well as college leagues, conducted extensive screening programs for COVID-induced myocarditis in 2020. They found a few cases that met the definition, but none were serious or resulted in hospitalizations or deaths. These screening programs were later discontinued when vaccines were introduced. However, within six months, regulatory agencies confirmed that the COVID-19 vaccines can cause myocarditis. It is important for people to understand that there is a risk of vaccine-induced myocarditis with every shot they take.

Before the COVID-19 vaccine, myocarditis cases were rare, with only 1 or 2 cases per year out of 15,021,000 autopsies. However, now it has become a common diagnosis, particularly among younger individuals.

Myocarditis, or heart inflammation, is more common than previously believed. Recent studies show that around 20% of individuals who received the COVID vaccine experience myocarditis, as confirmed by echocardiograms and other tests. This means that out of every 1 million vaccinated people, around 200,000 will have evidence of heart damage. Unfortunately, those who develop myocarditis have a 50% chance of surviving only 5 years. This alarming increase in myocarditis cases is due to the cardiotoxic nature of the vaccine. These facts, shared by Dr. Cussell and Shoemaker from Toronto, highlight the concerning impact of the vaccine on heart health.

In England and Wales, heart disease is a significant factor in COVID-19 deaths. Some believe vaccines may worsen heart conditions, with Dr. Thomas Levy estimating 2.8% of people receiving COVID injections experience heart injury. He suggests over 100 million Americans may have some level of heart damage from the vaccines, excluding myocarditis.

Before COVID-19, I only encountered two cases of myocarditis in my entire career as a cardiologist. However, now I see two cases per day in the clinic. We have learned that COVID-19 can cause myocarditis, and various organizations conducted screening programs in 2020. These programs found a few cases that met the definition of myocarditis, but none were serious or resulted in hospitalizations or deaths. After the introduction of vaccines, regulatory agencies acknowledged that the vaccines can cause COVID-19 vaccine-induced myocarditis, which can be fatal. It's important for people to understand that there is a risk associated with every vaccine shot they take.

As a cardiologist, the speaker states their role is to fight disease, preserve life, and do no harm. The topic is myocarditis or heart damage from the COVID-19 vaccines. The speaker claims to have examined thousands of patients with this problem, whereas before the pandemic, they state they only had two patients ever with this condition. The speaker references a New England Journal of Medicine paper from Washington University in St. Louis, August 18, 2021, where a 42-year-old man died three days after taking Moderna. They also cite a case from Korea by Choi and colleagues, where a younger man died within eight hours of being in the hospital after Pfizer. The speaker examined images from the Korean case and states the heart appeared "fried with inflammation" and "destroyed." The speaker concludes these cases should have gotten everyone's attention.

We are witnessing a surge in myocarditis cases post-vaccination, with numbers far exceeding pre-pandemic levels. Previously rare, I now see hundreds of cases in my practice, some fatal. Studies show up to 18,000 cases reported. The Hoelscher paper suggests vaccine-induced myocarditis as a likely cause of sudden adult death syndrome, with cases emerging years after vaccination. FDA regulations indicate a potential 15-year window of concern post-injection. This issue may be more widespread and long-lasting than we realize.

In October 2020, the FDA mentioned that myocarditis could be a result of the COVID vaccines. In June 2021, the FDA confirmed that the vaccines can cause heart inflammation. Prior to COVID, patients with myocarditis were advised not to exercise due to the risk of cardiac arrest. Now, there are 800 peer-reviewed papers on COVID vaccine-induced myocarditis. Two studies showed a 2.5% rate of heart damage after receiving the second or third vaccine dose. When heart damage occurs, there can be variations in electrical conduction, leading to reentry and fast heart rhythms like ventricular tachycardia. This can progress to ventricular fibrillation, which is fatal. A recent study confirmed that vaccine-induced myocarditis is always fatal.

Myocarditis is a small percentage of vaccine deaths, with clotting and bleeding being more common causes. Younger people dying means more life years lost. Vaccines have taken more life years than COVID in the US.